Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04161755
Title Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

pancreatic ductal adenocarcinoma

Therapies

Atezolizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + RO7198457

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.